Evidence

Use of a Genomic Test (MammaPrintâ„¢) in Daily Clinical Practice to Assist in Risk Stratification of Young Breast Cancer Patients

March 1, 2011

PUBLICATION: Arch Gynecol Obstet (2011) 283: 597. https://doi.org/10.1007/s00404-010-1454-9. AUTHORS: Kunz, G. SUMMARY: 44 patients had MammaPrint results and were eligible for the analysis. The results revealed a low risk result in 29 patients and a high risk result in 15 patients. Read more: Kunz_2011_Arch Gynecol Obstet._Use of a Genomic Test  

Read more